Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats

Experimental Neurology

Volumn 193, Issue 2, 2005, Pages 420-426

  Smith, A D ^a   Kozlowski, D A ^b,c   Bohn, M C ^b   Zigmond, M J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DEPAUL UNIVERSITY   (United States)

Author keywords

6 hydroxydopamine; Adenoviral vector; Dopamine; Gene therapy; Glial cell line derived neurotrophic factor; Microdialysis; Parkinson's disease

Indexed keywords

ADENOVIRUS VECTOR; AMPHETAMINE; BETA GALACTOSIDASE; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; PHOSPHATE BUFFERED SALINE; POTASSIUM CHLORIDE;

ANIMAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG EFFECT; IMMUNOREACTIVITY; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA;

EID: 18144409123     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.01.010     Document Type: Article

References (32)

1. E.D. Abercrombie, and M.J. Zigmond Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis J. Neurosci. 9 1989 4062 4067
2. E.D. Abercrombie, A.E. Bonatz, and M.J. Zigmond Effects of l-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats Brain Res. 525 1990 36 44
3. M. Bauer, S. Suppmann, M. Meyer, C. Hesslinger, T. Gasser, H.R. Widmer, and M. Ueffing Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones J. Neurochem. 82 2002 1300 1310
4. J.C. Bensadoun, N. Deglon, J.L. Tseng, J.L. Ridet, A.D. Zurn, and P. Aebischer Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF Exp. Neurol. 164 2000 15 24
5. A. Bilang-Bleuel, F. Revah, P. Colin, I. Locquet, J.J. Robert, J. Mallet, and P. Horellou Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 8818 8823
6. S.L. Castro, A.F. Sved, and M.J. Zigmond Increased neostriatal tyrosine hydroxylation during stress: role of extracellular dopamine and excitatory amino acids J. Neurochem. 66 1996 824 833
7. N.B. Chauhan, G.J. Siegel, and J.M. Lee Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain J. Chem. Neuroanat. 21 2001 277 288
8. D.L. Choi-Lundberg, Q. Lin, Y.N. Chang, Y.L. Chiang, C.M. Hay, H. Mohajeri, B.L. Davidson, and M.C. Bohn Dopaminergic neurons protected from degeneration by GDNF gene therapy Science 275 1997 838 841
9. D.L. Choi-Lundberg, Q. Lin, T. Schallert, D. Crippens, B.L. Davidson, Y.N. Chang, Y.L. Chiang, J. Qian, L. Bardwaj, and M.C. Bohn Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor Exp. Neurol. 154 1998 261 275
10. P.A. Garris, J.R. Christensen, G.V. Rebec, and R.M. Wightman Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats J. Neurochem. 68 1997 152 161
11. B. Georgievska, D. Kirik, and A. Björklund Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer Exp. Neurol. 177 2002 461 474
12. C. Gerin Behavioral improvement and dopamine release in a Parkinsonian rat model Neurosci. Lett. 330 2002 5 8
13. M.A. Hebert, and G.A. Gerhardt Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats J. Pharmacol. Exp. Ther. 282 1997 760 768
14. M.A. Hebert, C.G. Van Horne, B.J Hoffer, and G.A. Gerhardt Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis J. Pharmacol. Exp. Ther. 279 1996 1181 1190
15. K. Hirota, M. Kudo, T. Kudo, M. Kitayama, T. Kushikata, D.G. Lambert, and A. Matsuki Barbiturates inhibit K(+)-evoked noradrenaline and dopamine release from rat striatal slices-involvement of voltage sensitive Ca(2+) channels Neurosci. Lett. 291 2000 175 178
16. B.J. Hoffer, A. Hoffman, K. Bowenkamp, P. Huettl, J. Hudson, D. Martin, L.F. Lin, and G.A. Gerhardt Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo Neurosci. Lett. 182 1994 107 111
17. A.F. Hoffman, C.G. van Horne, S. Eken, B.J. Hoffer, and G.A. Gerhardt In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF Exp. Neurol. 147 1997 130 141
18. J. Hudson, A.C. Granholm, G.A. Gerhardt, M.A. Henry, A. Hoffman, P. Biddle, N.S. Leela, L. Mackerlova, J.D. Lile, F. Collins, and B.J. Hoffer Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo Brain Res. Bull. 36 1995 425 432
19. M.M. Iravani, S. Costa, M.J. Jackson, B.C. Tel, C. Cannizzaro, R.K. Pearce, and P. Jenner GDNF reverses priming for dyskinesia in MPTP-treated, l-DOPA-primed common marmosets Eur. J. Neurosci. 13 2001 597 608
20. C.M. Kearns, and D.M. Gash GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo Brain Res. 672 1995 104 111
21. J.H. Kordower, M.E. Emborg, J. Bloch, S.Y. Ma, Y. Chu, L. Leventhal, J. McBride, E.Y. Chen, S. Palfi, B.Z. Roitberg, W.D. Brown, J.E. Holden, R. Pyzalski, M.D. Taylor, P. Carvey, Z. Ling, D. Trono, P. Hantraye, N. Deglon, and P. Aebischer Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 2000 767 773
22. D.A. Kozlowski, B. Connor, J.L. Tillerson, T. Schallert, and M.C. Bohn Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections Exp. Neurol. 166 2000 1 15
23. P.A. Lapchak, S. Jiao, F. Collins, and P.J. Miller Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection Brain Res. 747 1997 92 102
24. L.F. Lin, D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1993 1130 1132
25. R.G. MacKenzie, M. Stachowiak, and M.J. Zigmond Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine Eur. J. Pharmacol. 168 1989 43 52
26. E.N. Pothos, V. Davila, and D. Sulzer Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size J. Neurosci. 18 1998 4106 4118
27. H. Sauer, C. Rosenblad, and A. Bjorklund Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion Proc. Natl. Acad. Sci. U. S. A. 92 1995 8935 8939
28. G.J. Siegel, and N.B. Chauhan Neurotrophic factors in Alzheimer's and Parkinson's disease brain Brain Res. Brain Res. Rev. 33 2000 199 227
29. A.D. Smith, M. Amalric, G.F. Koob, and M.J. Zigmond Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time Neuropsychopharmacology 26 2002 756 764
30. G.L. Snyder, R.W. Keller Jr., and M.J. Zigmond Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals J. Pharm. Exp. Ther. 253 1990 867 876
31. H. Xiao, Y. Hirata, K. Isobe, and K. Kiuchi Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines J. Neurochem. 82 2002 801 808
32. K. Xu, and D.E. Dluzen The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation Exp. Neurol. 166 2000 450 457